| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11908-008-0012-0 |
| P698 | PubMed publication ID | 18377818 |
| P2093 | author name string | Tendani Gaolathe | |
| Bisola Ojikutu | |||
| A T Makadzange | |||
| P2860 | cites work | Successful introduction of routine opt-out HIV testing in antenatal care in Botswana | Q40799377 |
| Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana | Q40799999 | ||
| Age at first sex and HIV infection in rural Zimbabwe | Q46818494 | ||
| Recent multiple sexual partners and HIV transmission risks among people living with HIV/AIDS in Botswana | Q37136335 | ||
| HIV decline associated with behavior change in eastern Zimbabwe | Q38879885 | ||
| Antiretroviral drugs for tuberculosis control in the era of HIV/AIDS. | Q39594941 | ||
| Establishment of a public antiretroviral treatment clinic for adults in urban Botswana: lessons learned | Q39713234 | ||
| P433 | issue | 1 | |
| P921 | main subject | Zimbabwe | Q954 |
| South Africa | Q258 | ||
| Botswana | Q963 | ||
| lessons learned | Q1673259 | ||
| P304 | page(s) | 69-73 | |
| P577 | publication date | 2008-03-01 | |
| P1433 | published in | Current infectious disease reports | Q26842136 |
| P1476 | title | Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and Botswana | |
| P478 | volume | 10 |
| Q40797394 | 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial |
| Q40458433 | Antiretroviral Drug Use in a Cross-Sectional Population Survey in Africa: NIMH Project Accept (HPTN 043). |
| Q34680326 | Bringing antiretroviral therapy (ART) closer to the end-user through mobile clinics and home-based ART: systematic review shows more evidence on the effectiveness and cost effectiveness is needed |
| Q35173497 | Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana |
| Q37256264 | Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSEN |
| Q46777679 | Health Without Care? Vulnerability, Medical Brain Drain, and Health Worker Responsibilities in Underserved Contexts. |
| Q36929552 | Immunohaematological reference values for HIV-negative healthy adults in Botswana |
| Q50073436 | Immunohaematological reference values for HIV-negative healthy adults in Botswana |
| Q40797865 | Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana |
| Q54204639 | Provision of antiretroviral therapy for children in Nelson Mandela Bay: Health care professionals' challenges. |
| Q37659742 | Systematic review and meta-analysis of the adolescent HIV continuum of care in South Africa: the Cresting Wave. |
| Q35327004 | Towards a family-centered approach to HIV treatment and care for HIV-exposed children, their mothers and their families in poorly resourced settings |
| Q35827900 | Treatment failure and drug resistance is more frequent in HIV-1 subtype D versus subtype A-infected Ugandans over a 10-year study period |
Search more.